Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: A delayed pandemic?
Introduction: SARS-CoV-2 was first detected in December 2019 in the Chinese city of Wuhan and has since spread across the world. At present, the virus has infected over 1.7 million people and caused over 100 000 deaths worldwide. Research is currently focused on understanding the acute infection and...
Main Authors: | P.J. Serrano-Castro, G. Estivill-Torrús, P. Cabezudo-García, J.A. Reyes-Bueno, N. Ciano Petersen, M.J. Aguilar-Castillo, J. Suárez-Pérez, M.D. Jiménez-Hernández, M.Á. Moya-Molina, B. Oliver-Martos, C. Arrabal-Gómez, F. Rodríguez de Fonseca |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2020-05-01
|
Series: | Neurología (English Edition) |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2173580820300572 |
Similar Items
-
Enfermedad periodontal como factor agravante de los pacientes con la COVID-19
by: Yaday Guerra Duarte, et al.
Published: (2021-12-01) -
La compleja y heterogénea evidencia que describe la biología celular en la neuroinflamación
by: Jhan Sebastian Saavedra Torres, et al.
Published: (2024-10-01) -
Encefalopatías espongiformes transmisibles: enfermedad crónica desgastante
by: M. A. Reyes-López, et al.
Published: (2006-01-01) -
Parkinson's disease: Present and future of cell therapy
by: F.J. Sancho-Bielsa
Published: (2022-01-01) -
Do patients diagnosed with a neurological disease present increased risk of suicide?
by: M. Alejos, et al.
Published: (2023-01-01)